Daoquan Peng
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
-
- Lipid metabolism and disorders 13
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 17
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 31
- Cholesterol and Lipid Metabolism 8
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 6
-
- Adipokines, Inflammation, and Metabolic Diseases 9
-
- Peroxisome Proliferator-Activated Receptors 7
Daoquan Peng
98 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Endocrinology, Diabetes and Metabolism 556
- Cardiology and Cardiovascular Medicine 593
- Cancer Research 333
- Surgery 682
- Immunology 289
Countries citing papers authored by Daoquan Peng
This map shows the geographic impact of Daoquan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoquan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoquan Peng more than expected).
Fields of papers citing papers by Daoquan Peng
This network shows the impact of papers produced by Daoquan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoquan Peng. The network helps show where Daoquan Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daoquan Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 26 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 3 | |
| 12 | 2019 | 30 | |
| 13 | 2018 | 57 | |
| 14 | 2015 | 9 | |
| 15 | 2015 | 45 | |
| 16 | 2014 | 61 | |
| 17 | 2012 | 3 | |
| 18 | 2011 | 21 | |
| 19 | 2008 | 1 | |
| 20 | 2008 | 44 |
About Daoquan Peng
Daoquan Peng is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 101 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (31 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Cancer, Lipids, and Metabolism (17 papers), Lipid metabolism and disorders (13 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers), Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (556 citations), Cardiology and Cardiovascular Medicine (593 citations) and Cancer Research (333 citations). Daoquan Peng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shui‐Ping Zhao, Xin Su, Mengdie Luo, Yi Wen Kong, Hao Wang, Shuai Wang, Bilian Yu, Shuhui Wang, Xin Su and Die Hu. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.